Mirosamicin

Anti-MCM8 minichromosome maintenance 8 homologous recombinat

Immunogen MIR16 (NP_057725.1, 1 a.

Anti-MSI1 musashi RNA binding protein 1, 100ul UN 1687 6.1 P

Anti-MSI1 musashi RNA binding protein 1, 100ul UN 1687 6.1 P

Anti-MSI1 musashi RNA-binding protein 1, 100ul UN 1687 6.1 P

Anti-MSI1 musashi RNA-binding protein 1, 25ul UN 1687 6.1 PG

Anti-MSI2 musashi RNA binding protein 2, 100ul UN 1687 6.1 P

Anticancer agent 73 (compound CIB-3b) is a anticancer agent, potently targeting TAR RNA-binding protein 2 (TRBP) and disrupts its interaction with Dicer. Anticancer agent 73 can rebalance the expression profile of oncogenic or tumor-suppressive

Anticancer agent 73 (compound CIB-3b) is a anticancer agent, potently targeting TAR RNA-binding protein 2 (TRBP) and disrupts its interaction with Dicer. Anticancer agent 73 can rebalance the expression profile of oncogenic or tumor-suppressive

Anticancer agent 73 (compound CIB-3b) is a anticancer agent, potently targeting TAR RNA-binding protein 2 (TRBP) and disrupts its interaction with Dicer. Anticancer agent 73 can rebalance the expression profile of oncogenic or tumor-suppressive

Anticancer agent 73 (compound CIB-3b) is a anticancer agent, potently targeting TAR RNA-binding protein 2 (TRBP) and disrupts its interaction with Dicer. Anticancer agent 73 can rebalance the expression profile of oncogenic or tumor-suppressive

Anticancer agent 73 (compound CIB-3b) is a anticancer agent, potently targeting TAR RNA-binding protein 2 (TRBP) and disrupts its interaction with Dicer. Anticancer agent 73 can rebalance the expression profile of oncogenic or tumor-suppressive